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Sandra A. Banta-Wright,1 Nancy Press,2 Kathleen A. Knafl,3 Robert D. Steiner,4 and Gail M. Houck1
Abstract
Objective: This study described the prevalence and duration of mothers’ breastfeeding infants with phenylke-
tonuria (PKU) and explored factors related to duration of breastfeeding as a surrogate for breastfeeding success.
Subjects and Methods: Descriptive analysis as performed from an international Internet survey of mothers
(n= 103) who met the inclusion criteria: (1) at least 21 years of age, (2) able to read and write in English, (3) child
with PKU, and (4) living in the United States or Canada.
Results: Of the 103 mothers, 89 (86%) initiated breastfeeding immediately following delivery, whereas 14 (14%)
chose bottle feeding. In comparison to breastfeeding after delivery, significantly fewer mothers breastfed after
diagnosis (McNemar’s v2 = 30.33, p < 0.001; n = 72 vs. n= 89). Breastfeeding duration ranged from less than 1
month to 24 months with one modal duration category (n = 20, 22%) at less than 1 month. The timing of the
addition of commercial infant formula to supplement breastfeeding or expressed mothers’ milk was associated
with a shorter duration of breastfeeding among infants with PKU: v2 (42, n= 73) = 88.13, p < 0.001.
Conclusions: PKU is treated with phenylalanine (Phe) restriction. Breastfeeding infants with PKU is challenging
in part because Phe intake is difficult to determine precisely. We studied breastfeeding duration in infants with
PKU and factors associated with success. Further research should identify the unique needs of mothers’
breastfeeding infants with PKU to guide the development of interventions specific to these mothers to support
their efforts to continue breastfeeding after the diagnosis of PKU.
Introduction
During the early years of phenylketonuria (PKU)treatment, the standard of care for infants diagnosed
with PKU included immediate weaning from breastfeeding
and institution of phenylalanine (Phe)-free or low-Phe medi-
cal beverage in conjunction with standard commercial infant
formula to maintain appropriate Phe levels (120–360 lmol/
L).1–3 At the time, this was believed to be the only effective
way to monitor the infant’s intake and allow for precise ti-
tration and measurement of Phe to protect the neurological
and cognitive development of the infant. Consequently, this
management approach precluded breastfeeding infants with
PKU. However, breastmilk offers several advantages when
used as a primary source of nutrition for infants with PKU.
These include the benefits of breastfeeding for any infant4,5
and that breastmilk is lower in Phe than standard commercial
infant formulas.6,7
Studying breastfeeding in PKU is challenging. Breastfeed-
ing in the context of PKU, defined as breastfeeding and bot-
tle feeding of expressed mothers’ milk to infants, entails
the need for mothers, at each feeding, to estimate how long to
breastfeed or how much breastmilk to bottle feed, as well as
to estimate how much Phe-free supplementation is required
to maintain acceptable blood Phe levels. Although based on
relatively small samples of fewer than 50 participants due to
PKU’s rarity, study results comparing infants with PKU fed
breastmilk and supplemented with Phe-free medical bever-
age versus those exclusively formula fed consistently have
reported that breastmilk supplemented with Phe-free medical
beverage was an acceptable dietary treatment for infants with
PKU as Phe levels could be maintained within the desired
range.2,3,8–11 Among women with a child with PKU, there are
no large-scale studies reporting the variables related to
breastfeeding duration with duration taken as a measure of
‘‘breastfeeding success.’’ Nonetheless, studies of overall
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prevalence of breastfeeding have found the following vari-
ables to be linked to duration: older maternal age, white,
married status, greater social support, and normal vaginal
delivery improve duration, whereas infant health problems
shorten duration.12–14
Although the practice of breastfeeding infants with PKU
has been discussed in the literature, there is limited research
describing patterns of breastfeeding in mothers of infants with
PKU.2,3,9–11,15–18 It is notable that there is no published re-
search identifying factors associated with breastfeeding du-
ration within this unique population of breastfeeding mothers
or to support clinical guidelines that specifically address the
unique challenges of mothers breastfeeding infants with PKU.
Therefore, the purpose of this analysis was to describe the
prevalence and duration of breastfeeding among mothers of
infants with PKU living in the United States and Canada and
to identify factors that affected the duration and success of
breastfeeding in this unique population.
Subjects and Methods
This was a descriptive study of data from an international
Internet survey conducted to explore mothers’ current or retro-
spective experiences breastfeeding infants with PKU. The In-
ternet survey took place between November 2010 and May
2011. The sample comprised women who met the following
criteria: at least 21 years of age, able to read and write in English,
had a child or children with PKU regardless of current age, and
lived in the United States or Canada. In this study, breastfeed-
ing included the bottle feeding of expressed mothers’ milk.
The survey consisted of a questionnaire that contained
sections about the demographic characteristics of mothers
and infants and infant feeding history. Response options in-
cluded both forced choice and open-ended questions. Six
mothers of children with PKU pilot-tested the questionnaire
and online survey, and their input was used to make final
revisions in the survey in order to refine and improve the
approach and wording of the questions.
After approval was received from the university’s institu-
tional review board, the study was announced on the PKU
Listserv. The purpose of this listserv is to facilitate communi-
cation among families of children born with PKU and to share
information, advice, and experiences of living with PKU.
Subsequently, several regional and national PKU support
groups (n= 14) used the original or modified university-
approved announcement of the study to communicate its
availability to their members. The posting included a brief
description of the purpose of the study and the inclusion cri-
teria with the instruction that interested participants should
reply directly to the researcher (S.A.B.-W.) by e-mail. Mothers
who responded to the recruitment post were e-mailed a copy
of the research information sheet and instructions for the
survey. The university’s institutional review board waived the
requirement for a formal written consent. The mean duration
for mothers to complete the survey was 19 minutes (SD= 10
minutes) with a range from 7 to 69 minutes. Mothers who
completed the survey were sent a $10 (U.S.) electronic gift
certificate to a medical foods company that provides low
protein items popular with families who have individuals
with PKU. Of the 149 women who received the information
sheet and instructions for the Internet survey, 119 completed
the Internet survey for a return rate of approximately 80%.
After the Internet survey was closed, data were down-
loaded into an SPSS (Chicago, IL) software file and compared,
and all discrepancies were resolved by checking the hard copy
of each participant’s data. Statistical analysis was performed
with SPSS Windows (version 19.0) software. For binary de-
pendent variables within-subjects, the v2 test was applied to
analyze the difference between the proportion of mothers
who breastfed immediately after delivery and the proportion
of mothers who continued breastfeeding after the diagnosis of
PKU. Pearson’s v2 test was used to analyze the statistical re-
lationship between duration of breastfeeding and variables
known to affect breastfeeding duration. A p value of < 0.05
was considered statistically significant.
Results
Demographics
The final sample was comprised of mothers (n = 119)
consisting of two groups: mothers with one child who had
PKU (n = 103, 87%) and mothers with more than one child
with PKU (n = 16, 13%). Only data from the 103 mothers with
one child with PKU are included in this report. Demographic
characteristics of the mothers are presented in Table 1 and
those of the infants in Table 2. Mothers were from various
regions across the United States and Canada (Fig. 1). De-
mographic features of the mothers closely match another
survey of parents with children who have PKU.19 In ad-
dition, this sample was consistent with the known ethnic
distribution of PKU, with a higher incidence in individuals
of Northern European ancestry than black, Hispanic, and
Asian individuals.20–23
What is the prevalence of breastfeeding prior
to and after diagnosis of PKU?
Of the 103 mothers with one child with PKU, 89 mothers
(86%) initiated breastfeeding, and 14 mothers (14%) began
bottle feeding immediately after delivery. After diagnosis, 18
mothers switched from breastfeeding to bottle feeding for-
mula, whereas one mother initiated breastfeeding. An ad hoc
analysis using McNemar’s test was performed to assess the
difference between the proportion of mothers who breastfed
immediately after delivery and the proportion of mothers
who continued breastfeeding after the diagnosis of PKU (Fig.
2). There were significantly fewer mothers breastfeeding after
diagnosis (McNemar’s v2 = 30.333, p< 0.001; n = 72 vs. n = 89).
Given the significance of fewer mothers breastfeeding after
diagnosis, another ad hoc analysis was conducted to ascertain
whether this significance differed by country, as Canadian
breastfeeding rates are higher than United States breastfeed-
ing rates for ever-breastfed (90.3% vs. 73.9%).24 Of the 89
mothers who breastfed after delivery, 75 (84%) were mothers
from the United States, and 14 (16%) were mothers from
Canada. After diagnosis, 60 mothers (80%) from the United
States continued to breastfeed, whereas 15 mothers (20%)
switched to bottle feeding. In contrast, only two Canadian
mothers switched from breastfeeding to bottle feeding after
the diagnosis of their infants having PKU. Using McNemar’s
test with layering of the United States and Canada, the sig-
nificant reduction in breastfeeding mothers was a function of
women from the United States (McNemar’s v2= 27.48,
p< 0.001; n = 60 vs. n= 75) and not from Canada (Fig. 2).
What is the duration of breastfeeding for mothers
of infants with PKU who breastfeed?
Among mothers in this study, the duration of breastfeeding
(including bottle feeding of expressed mothers’ milk) ranged
from less than 1 month (n= 20, 22%) to 24 months (n = 5, 5%).
Although the modal duration category was at less than 1
month (n= 20, 22%), over three-fourths of the mothers
breastfed their infants with PKU longer than 1 month, and
over one-half breastfed to 6 months. Table 3 gives the distri-
bution of duration of breastfeeding categories.
What factors are related to duration of breastfeeding
in mothers of infants with PKU?
Several factors were assessed in relation to the duration of
breastfeeding using v2 analysis. Only one variable—the tim-
ing of when standard commercial infant formula was added
Table 2. Demographic Characteristics
of Infants with Phenylketonuria
United States
(n = 89)
Canada
(n = 14)
Gender (male/female) 38/51 10/4
Birth weight (kg)a 3.44 (2–5) 3.44 (1–4)
Term gestation 78 (88%) 11 (79%)
Uncomplicated
pregnancies
80 (89%) 13 (93%)
Phe level (lmol/L)
at diagnosisa
969 (240–2,520) 810 (252–2,400)
Age (days) at diagnosisa 4 (1–28) 4 (1–14)
Infants born between
2000 and 2011
77 (86%) 13 (93%)
aData are mean values (minimum–maximum are given in paren-
theses).
Phe, phenylalanine.
FIG. 1. Geographic location of surveyed mothers of in-
fants with phenylketonuria living in the United States and
Canada.
Table 1. Demographic Characteristics of Mothers
of Infants with Phenylketonuria
Variable
United States
(n = 89)
Canada
(n = 14)
Maternal age (years)
21–29 16 (18) 2 (14)
30–39 54 (61) 10 (72)
40–49 14 (16) 2 (14)
50–65 5 (5) 0
Ethnicity
Asian/Pacific Islander 1 (1) 0
White 83 (93) 12 (86)
Hispanic/Latino 5 (6) 0
First Nation/Inuit 0 2 (14)
Marital status
Never married or partnered 2 (2) 1 (7)
Living with partner 0 (0) 3 (22)
Married 82 (92) 9 (64)
Separated 1 (1) 1 (7)
Divorced 4 (5) 0
Educationa
High school 2 (2) 1 (7)
Some college 11 (12) 2 (14)
Associates degree 13 (15) 2 (14)
Bachelors degree 34 (38) 4 (29)
Masters degree 21 (24) 4 (29)
Doctorate degree 5 (6) 0
Professional degree 3 (3) 1 (7)
Employment (hours per week)
0 28 (31) 3 (21)
< 8 4 (4) 0
10–16 2 (2) 2 (14)
20–38 21 (24) 4 (29)
40 29 (33) 4 (29)
> 40 5 (6) 1 (7)
Gross annual household incomeb,c
< $25,000 3 (4) 1 (7)
$25,001–$50,000 8 (9) 4 (29)
$50,001–$75,000 18 (21) 2 (14)
$75,001–$100,000 30 (35) 2 (14)
$100,001–$150,000 12 (14) 4 (29)
> $150,000 14 (17) 1 (7)
Community population size
A town with a population < 10,000 17 (19) 1 (7)
A city with a population between
10,000 and 50,000
30 (34) 6 (43)
A city with a population between
50,001 and 100,000
13 (15) 1 (7)
A metropolitan area with a population
between 100,001 and 500,000
10 (11) 4 (29)
A metropolitan area with a
population between 500,001
to 1 million
8 (9) 2 (14)
A metropolitan area with a
population > 1 million
11 (12) 0
Data are n (%).
aHighest level of education completed.
bIn U.S. dollars.
cU.S. mothers, n = 85.
to diet replacing some or all breastmilk from nursing or ex-
pressed mothers’ milk—was significantly associated with
decreased duration of breastfeeding (including expressed
mothers’ milk) for infants with PKU: v2 (36, n = 71) = 89.68,
p < 0.001. Almost one-third of mothers (n = 26) reported the
challenge of decreased breastmilk supply and the need to add
standard commercial infant formula. Of those identifying
when standard commercial formula was added to the infant’s
diet, approximately 30% (n = 21) had added it by 6 months.
Almost one-half of the mothers (n= 34, 48%) never introduced
standard commercial infant formula to their infant’s diet; ra-
ther, they transitioned from breastfeeding to the introduction
of solid foods with Phe-free/low-Phe medical beverage as the
‘‘milk’’ source.
Discussion
In this study, a high percentage of mothers (n= 72, 81%)
continued breastfeeding after their infant’s diagnosis of PKU.
Breastfeeding an infant with PKU, who requires careful mon-
itoring of Phe intake due to the need to restrict Phe intake and
titrate intake with blood Phe levels, can be challenging for
mothers and healthcare providers. Difficulties arise because it
is difficult to determine the quantity of Phe ingested by the
infant because of variability of Phe content in breastmilk and
volume of breastmilk consumed. Therefore, the high preva-
lence of continuation of breastfeeding after PKU diagnosis is
impressive. The supports and strategies used by mothers that
facilitated breastfeeding success while maintaining desired Phe
levels should be incorporated into the management of breast-
feeding infants with PKU and will be reported elsewhere.25
Despite the increased work associated with breastfeeding a
child with PKU, a substantial number of these mothers did so,
with the sample as a whole meeting or exceeding the majority
of breastfeeding percentages reported in both the United
States and Canada. In comparison with U.S. National Breast-
feeding Percentages,26 this group of mothers exceeded the
expected rate of breastfeeding initiation (86% vs. 77%) and
breastfeeding at 6 months (55% vs. 47%) but did not meet the
expected rate of breastfeeding at 12 months (17% vs. 26%). In
addition, the mothers were comparable to the Canadian
3-month breastfeeding rates for any breastfeeding (65% vs.
68%) and to the 6-month breastfeeding rate (55% vs. 54%).27
Furthermore, these mothers nearly met the Canadian initia-
tion rate for breastfeeding (86% vs. 90%). In comparison with
the Healthy People 2020 Breastfeeding Objectives,28 mothers
exceeded the goal for the initiation of breastfeeding (86% vs.
82%) but did not meet the breastfeeding objectives at
6 months (55% vs. 61%) or 12 months (17% vs. 34%). Almost
70% of mothers (n = 48) met the American Academy of Pe-
diatrics29 and the Canadian Paediatric Society30 breastfeeding
recommendation of 6 months. This drop off over time in
breastfeeding by mothers of infants with PKU perhaps reflects
FIG. 2. Comparison of breastfeeding prevalence prior to diagnosis and after diagnosis of phenylketonuria: breastfeeding
and bottle feeding (left panel) before and after diagnosis of phenylketonuria and (right panel) according to country of
residence before and after diagnosis.
Table 3. Duration of Breastfeeding
Breastfeeding duration United States (n= 76) Canada (n = 14)
< 1 month 18 (20%) 2 (2%)
1–3 months 10 (11%) 3 (3%)
4–6 months 7 (8%) 2 (2%)
7–9 months 12 (14%) 3 (3%)
10–12 months 16 (18%) 3 (3%)
13–18 months 9 (10%) 0
19–24 months 4 (5%) 1 (1%)
Data are n (%).
the ongoing demands of managing PKU therapy. A phar-
macologic treatment for PKU was U.S. Food and Drug Ad-
ministration approved in 2007 and might eventually be used
in infants with PKU, but currently use of sapropterin dihy-
drochloride (Kuvan; Biomarin, Novato, CA) is limited to
children over 4 years of age.31
In this sample, mothers’ with infants who have PKU from
the United States and Canada on average breastfed longer
than mothers with infants who have PKU from other coun-
tries in Europe, Asia, and South America reported by other
investigators.3,10,11,15–17 Those studies consistently reported
that the majority of mothers who were breastfeeding infants
with PKU did not persist as long as mothers’ breastfeeding
healthy infants without PKU. Given that statistics for the in-
cidence and duration of breastfeeding infants with PKU from
countries outside North America are at least a decade old,
current data might reveal more similar rates. Alternatively,
the current study included mothers reporting current and
retrospective experiences, and the rate and duration may re-
flect those who felt successful and therefore responded to the
survey.
Biological and social demographic characteristics that
might have influenced breastfeeding duration were likely not
manifested in this study because of the homogeneous demo-
graphic characteristics of the sample, which was predomi-
nantly white, well-educated, and older mothers, who
characteristically have been associated with higher rates of
breastfeeding.12–14 Yet, breastfeeding duration rates were re-
markable considering the substantial effort required to
breastfeed for these mothers. These mothers breastfed, bottle
fed Phe-free medical beverage, breast pumped after bottle
feeding Phe-free medical beverage to maintain their breast-
milk supply, and obtained once to twice weekly in-home in-
fant Phe blood samples for laboratory analysis.
The only variable that was linked to breastfeeding duration
was when standard commercial infant formula was added
into the infant’s diet, thereby replacing breastfeeding or
pumped expressed mothers’ milk. This finding is consistent
with the observations of other researchers,32 who identified
formula supplementation in breastfed infants as a strong
predictor for the discontinuation of breastfeeding in other
healthy non-PKU populations. It is also possible that chal-
lenges maintaining breastmilk supply necessitated supple-
mentation, which in turn further diminished breastmilk
supply and encouraged discontinuation of breastfeeding.
Less is known about factors that affect the duration of
breastfeeding infants with PKU. In this study, approximately
one-third of the mothers (n = 33) breastfed to their infant’s first
birthday, suggesting these mothers were able to maintain
lactation and further adapt their breastfeeding with the in-
troduction of solid foods. Yet, more than 20% of mothers
(n = 20) stopped breastfeeding prior to their infant being a
month of age; by 6 months, more than 45% of mothers (n = 41)
stopped breastfeeding. This is consistent with other re-
searchers who have found that the majority of all mothers
who stop breastfeeding healthy infants without PKU do so in
the first 6 months.33,34 This suggests that mothers who are
breastfeeding infants with PKU may need more support
during the early weeks after diagnosis and again when low-
Phe table foods are introduced at around 6 months. Although
some barriers and challenges to breastfeeding infants with
PKU35 have been identified, the role that metabolic clinics
play in the continuation or discontinuation of breastfeeding
infants with PKU should be investigated further.
This study has several limitations and strengths. Even
though this convenience sample population was drawn from
the Internet with mothers living in various regions across the
United States and Canada, from small rural communities to
large metropolitan cities, the sample was representative of
highly educated, married/partnered mothers who may not be
representative of the larger population of mothers with chil-
dren who have PKU in the United States and Canada. In ad-
dition, the sample ethnicity was overwhelmingly white, but
this is consistent with the known ethnic distribution of PKU
having a higher incidence in individuals of Northern European
ancestry than black, Hispanic, and Asian individuals.14,20–22
Furthermore, the sample characteristics were consistent with
those who use the Internet for health and other purposes as
they tend to be more educated and affluent than those who do
not.36 Consequently, mothers who read and post to the PKU
Listserv may be more educated regardless of geographic resi-
dence than the general population of mothers with children
who have PKU, a population for whom demographic charac-
teristics are not known. Further research is needed to include
mothers of breastfeeding infants with PKU across the socio-
economic spectrum, especially those with incomes less than
$50,000 per year, who are of non–Northern European heritage,
and have limited computer access.
This was a quantitative descriptive study with an unequal
distribution between United States and Canadian mothers (89
vs. 14, respectively) who have infants with PKU. This unequal
distribution could be the result of the population difference
between the United States and Canada and most likely reflects
the fact the United States has a 10-fold larger population37,38
and a somewhat higher reported incidence of PKU39 (1:10,000–
1:20,000) than Canada22,40 (1:15,000–1:22,000), resulting in a
difference of 400 infants with PKU born in the United States
each year versus only 26 infants with PKU in Canada. In ad-
dition, there was the difference in the announcement of the
study in the United States and Canada. The study was origi-
nally announced on the PKU Listserv. Afterward, the study
was announced on the Canadian PKU and Allied Disorders
Web site and newsletter. In the United States, the study was
announced on several regional PKU organizations Web pages
(n= 5) and Facebook pages (n= 3), while other regional PKU
organizations (n= 6) e-mailed or twittered their members
along with announcements in regional newsletters (n= 2).
Future studies need to have improved recruitment strategies
for Canadian mothers to participate.
In this sample, the majority of breastfed infants with PKU
(n= 82, 92%) were born at term, with only seven breastfed
infants who were born premature, which could have affected
breastfeeding duration due to trouble with latching and
suckling.41 Re-analysis of the data excluding these seven in-
fants did not change the results.
In this study, the purpose was to describe the prevalence and
duration of breastfeeding for infants with PKU in the United
States and Canada regardless of their metabolic clinic location.
Consequently, comparison of Phe levels between breastfed and
formula-fed infants with PKU was not conducted. Previous
studies2,3,8–11,18 have consistently reported that breastmilk
supplemented with Phe-free medical beverage is an acceptable
dietary treatment for infants with PKU as Phe levels could be
maintained within the desired range.
Breastfeeding and feeding expressed mothers’ milk were
used by mothers to provide breastmilk to their infants with
PKU. In addition, these mothers were bottle feeding Phe-
free medical beverage, breast pumping after bottle feed-
ing in order to maintain breastmilk supply, and performing
in-home heel-stick blood sampling once to twice weekly and
sending dried, blood-soaked filter paper to a laboratory for
Phe analysis. With blood Phe results, adjustments are made
in Phe intake by altering the ratio of breastfeeding/feeding
expressed mothers’ milk to Phe-free medical beverage
feeding. In this study, then, ‘‘breastfeeding in the context of
PKU’’ was used to describe the work of providing breastmilk
to infants with PKU. The survey did not ask mothers to
clarify how they provided breastmilk, but rather whether
they did provide breastmilk and how long they provided
breastmilk to their infant with PKU. In the future, clarifica-
tion of how infants with PKU receive breastmilk, by breast or
bottle, should be obtained to further explore the breastmilk
feeding issues that arise from different methods of providing
breastmilk.
Our estimates of breastfeeding were based on maternal
recall of breastfeeding experiences with infants who have
PKU, which ranged between 7 months to 27 years after the
birth of the child with PKU. For some mothers, the length of
time after birth may have affected their ability to recall their
experiences.42 Despite the varying lengths of time since birth
of the child with PKU, a review of the literature revealed no
information regarding the prevalence and duration of
breastfeeding infants with PKU from countries in North
America. This study provided the first exploration of the
prevalence and duration of breastfeeding in the context of
PKU from North America.
Conclusions
This study provides further evidence that mothers of in-
fants with PKU can successfully breastfeed, allowing expo-
sure to the benefits of breastmilk and, in many cases,
breastfeeding. Consequently, mothers with newly diag-
nosed breastfeeding infants with PKU and who had planned
to breastfeed should be supported and encouraged to con-
tinue breastfeeding. It is imperative that healthcare provid-
ers who provide metabolic and nutritional care to mothers of
infants with PKU reinforce that mothers’ breastmilk remains
the optimal base feeding for their infants with PKU. Addi-
tional research is needed to explore the types of supports
these mothers need to successfully maintain breastfeeding in
the context of managing the disorder of PKU for their infants.
Such research will provide the needed information to con-
tribute to the identification of effective strategies for im-
proved clinical management of breastfeeding in the context
of PKU.
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